Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine effects on hippocampal and neurochemical changes in bipolar disorder
2007-000479-40Phase 2Active
- Sponsor
- RWTH Aachen University
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of quetiapine in bipolar disorder (BD), sponsored by RWTH Aachen University. Primary endpoint: Anisotropy in hippocampal formation detected with Diffusion Tensor Imaging. Started Feb 2009; status: active.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2007-000479-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000479-40.